In this regard, increased TCN2 levels were previously reported in patients with a variety of inflammatory and lymphoproliferative disorders, including those diagnosed with multiple myeloma and Waldenstrom macroglobulinemia experiencing overproduction of immunoglobulins (hyperglobulinemia) (140). Here, TCN2 is linked to AL amyloidosis.